Co-occurrence of Trichomonas vaginalis and bacterial vaginosis and vaginal shedding of HIV-1 RNA

Sexually Transmitted Diseases

Volumn 41, Issue 3, 2014, Pages 173-179

  Fastring, Danielle R ^a,b   Amedee, Angela ^c   Gatski, Megan ^a   Clark, Rebecca A ^c   Mena, Leandro A ^d   Levison, Judy ^e   Schmidt, Norine ^a   Rice, Janet ^a   Gustat, Jeanette ^a   Kissinger, Patricia ^a  

^a TULANE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN MISSISSIPPI   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANDIDIASIS, VULVOVAGINAL; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; PREVALENCE; RNA, VIRAL; SEXUAL BEHAVIOR; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; UNITED STATES; URBAN POPULATION; VAGINA; VAGINAL DISCHARGE; VAGINOSIS, BACTERIAL; VIRAL LOAD; VIRUS SHEDDING;

EID: 84894485060     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000089     Document Type: Article

References (63)

1. Petrin D, Delgaty K, Bhatt R, et al. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998; 11: 300-317
2. CDC. Sexually transmitted disease treatment guidelines. MMWR 2006; 55
3. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698
4. Demirezen S, Korkmaz E, Beksac MS. Association between trichomoniasis and bacterial vaginosis: Examiniation of 600 cervicovaginal smears. Cent Eur J Public Healt 2005; 13:96-98
5. Brogly SB, Watts DH, Ylitalo N, et al. Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health 2007; 97:1047-1052
6. Cu-Uvin S, Ko H, Jamieson DJ, et al. Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)Ypositive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis 2002; 34: 1406-1411
7. Magnus M, Clark R, Myers L, et al. Trichomonas vaginalis among HIV-Infected women: Are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Sex Transm Dis 2003; 30:839-843
8. Miller M, Liao Y, Wagner M, et al. HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. Sex Transm Dis 2008; 35:696-702
9. Moodley P, Wilkinson D, Connolly C, et al. Influence of HIV-1 coinfection on effective management of abnormal vaginal discharge. Sex Transm Dis 2003; 30:1-5
10. Watts DH, Springer G, Minkoff H, et al. The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: Longitudinal findings of the women's interagency HIV study. J Acquir Immune Defic Syndr 2006; 43:161-168
11. Gatski M, Martin DH, Clark RA, et al. Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis 2011; 38:163-166
12. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey Data. Obstet Gynecol 2007; 109:114-120
13. Balkus JE, Richardson BA, Mochache V, et al. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIVseronegative women. Sex Transm Dis 2013; 40:499-505
14. Sha BE, Zariffard MR, Wang Qiong J, et al. Female genital tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005; 191:25-32
15. Cu-Uvin S, Hogan JW, Caliendo AM, et al. Association between bacterial vaginosis and epression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect dis 2001; 33:894
16. Spinillo A, Debiaggi M, Zara F, et al. Factors associated with nucleic acids related to HIV-1 cervico-vaginal secretions. BJOG 2001; 108:634-641
17. Kissinger P, Amedee A, Clark RA, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis 2009; 36:11
18. Wang CC, McClelland RS, Kreiss JK, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001; 183:1017
19. Theall KP, Amedee A, Clark RA, et al. Alcohol consumption and HIV-1 vaginal RNA shedding among women. J Stud Alcohol Drugs 2008; 69:454-458
20. Coleman JS, Hitti J, Bukusi EA, et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. J Acquir Immune Defic Syndr 2007; 21:755-759
21. Cummins JE, Christensen L, Lennox JL, et al. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load. AIDS Res Hum Retroviruses 2006; 22:788-795
22. Cowan FF, Pascoe SJS, Barlow KL, et al. Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe. J Acquir Immune Defic Syndr 2006; 20:261
23. Fiore JR, Suligoi B, Saracino A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. J Acquir Immune Defic Syndr 2003; 17:2169-2176
24. Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2013. http://aidsinfo.nih.gov/ contentfiles/lvguidelines/ AdultandAdolescentGL.pdf
25. CDC. HIV in the United States: The Stages of Care. 2012
26. Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev 2009; 22:37
27. Johnston VJ, Mabey DC. Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infect Dis 2008; 21:56-64
28. Allsworth JE, Ratner JA, Peipert JF. Trichomoniasis and other sexually transmitted infections: Results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex Transm Dis 2009; 36:738
29. Henning TR, Kissinger P, Lacour N, et al. Elevated cervical white blood cell infiltrate is associated with genital HIV detection in a longitudinal cohort of antiretroviral therapyYadherent women. J Infect Dis 2010; 202:1543-1552
30. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921-929
31. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA 1991; 266:1664-1667
32. Panther LA, Tucker L, Xu C, et al. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatalHIV-1 transmission. J InfectDis 2000; 181:555-563
33. Gaillard P, Verhofstede C, Mwanyumba F, et al. Exposure to HIV-1 during delivery and mother-to-child transmission. J Acquir Immune Defic Syndr 2000; 14:2341-2348
34. Tuomala RE, O'Driscoll PT, Bremer JW, et al. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 2003; 187:375
35. Kissinger P, Mena L, Levison J, et al. A randomized treatment trial: Single versus 7 day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr 2010; 55:565-571
36. Nugent R, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301
37. Miller CJ, Shattock RJ. Target cells in vaginal HIV transmission. Microbes Infect 2003; 5:59-67
38. Rebbapragada A, Howe K, Wachihi C, et al. Bacterial vaginosis in HIV-Infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 2008; 49: 520-522
39. Mitchell C, Moreira C, Fredricks D, et al. Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis. Infect Dis Obstet Gynecol 2009; 2009:1-6
40. Thurman AR, Doncel GF. Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: Relationship to HIVacquisition. Am J Reprod Immunol 2011; 65:89-98
41. Cauci S, Culhane JF. Modulation of vaginal immune response among pregnant women with bacterial vaginosis by Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and yeast. Am J Obstet Gynecol 2007; 196:133.e1-133.e7
42. Narimatsu R, Wolday D, Patterson BK. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses 2005; 21:228-233
43. Cole AM, A.L. C. Antimicrobial Polypeptides are Key Anti-HIV-1 Effector Molecules of Cervicovaginal Host Defense. Am J Reprod Immunol 2008; 59:27-34
44. Mane A, Kulkarni S, Ghate M, et al. HIV-1 RNA shedding in the female genital tract is associated with reduced quantity of Lactobacilli in clinically asymptomatic HIV-positivewomen. DiagnMicrobiol Infect Dis 2013; 75:112-114
45. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350: 922-927
46. Kovacs A, Wasserman SS, Burns D, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001; 358:1593
47. Graham SM, Holte SE, Peshu NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. J Acquir Immune Defic Syndr 2007; 21:501-507
48. Clark RA, Theall KP, Amedee AM, et al. Frequent douching and clinical outcomes among HIV-infected women. Sex Transm Dis 2007; 34:985
49. McClelland RS, Baeten JM, Richardson BA, et al. A comparison of genital HIV-1 shedding and sexual risk behavior among Kenyan women based on eligibility for initiation of HAART according to WHO guidelines. J Acquir Immune Defic Syndr 2006; 41:611-615
50. Iversen AKN, Attermann J, Gerstoft J, et al. Longitudinal and crosssectional studies of HIV-1 RNA and DNA loads in blood and the female genital tract. Eur J Obstet Gynecol Reprod Biol 2004; 117:227
51. Sorvillo F, Smith L, Kerndt P, et al. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7:927
52. McClelland RS, Wang CC, Mandaliya K, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. J Acquir Immune Defic Syndr 2001; 15:105-110
53. Reichelderfer PS, Coombs RW, Wright DJ, et al. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. J Acquir Immune Defic Syndr 2000; 14:2101-2107
54. Kovacs A, Chan LS, Chen ZC, et al. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1. J Acquir Immune Defic Syndr 1999; 22:124
55. Iversen AKN. Genital HIV shedding in women. AIDS Patient Care STDS 1999; 13:695
56. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349:1868
57. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: A systematic review and metaanalysis. Sex Transm Dis 2008; 35:946-959
58. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr 1997; 11:F85YF93
59. Gatski M, Martin DH, Levison J, et al. The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect 2011; 87:205-208
60. Kissinger P, Adamski A, Clark RA, et al. Does antiretroviral therapy interfere with the treatment of Trichomonas vaginalis among HIV+ women? Sex Transm Dis 2013; 40:506-507
61. Benki S,Mostad SB, Richardson BA, et al. Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle. J Infect Dis 2004; 189:2192
62. Rivers CA, Muzny CA, Schwebke Jr. Diagnostic rates vary based upon the number the number of read days using the Trichomonas vaginalis InPouch culture system. J Clin Microbiol 2013; 51: 3875-3876
63. Menard JP, Mazouni C, Fenollar F, et al. Diagnostic accuracy of quantitative real-time PCR assay versus clinical and Gram stain identification of bacterial vaginosis. Eur J Clin Microbiol Infect Dis 2010; 29:1547-1552